At kr.224, Is cBrain A/S (CPH:CBRAIN) Worth Looking At Closely?

cBrain A/S (CPH:CBRAIN), is not the largest company out there, but it received a lot of attention from a substantial price increase on the CPSE over the last few months. While good news for shareholders, the company has traded much higher in the past year. Less-covered, small caps tend to present more of an opportunity for mispricing due to the lack of information available to the public, which can be a good thing. So, could the stock still be trading at a low price relative to its actual value? Today we will analyse the most recent data on cBrain’s outlook and valuation to see if the opportunity still exists.

Advertisement

What Is cBrain Worth?

cBrain appears to be expensive according to our price multiple model, which makes a comparison between the company's price-to-earnings ratio and the industry average. In this instance, we’ve used the price-to-earnings (PE) ratio given that there is not enough information to reliably forecast the stock’s cash flows. We find that cBrain’s ratio of 67.61x is above its peer average of 28.96x, which suggests the stock is trading at a higher price compared to the Software industry. But, is there another opportunity to buy low in the future? Given that cBrain’s share is fairly volatile (i.e. its price movements are magnified relative to the rest of the market) this could mean the price can sink lower, giving us another chance to buy in the future. This is based on its high beta, which is a good indicator for share price volatility.

View our latest analysis for cBrain

What kind of growth will cBrain generate?

earnings-and-revenue-growth
CPSE:CBRAIN Earnings and Revenue Growth July 18th 2025

Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Although value investors would argue that it’s the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. cBrain's earnings over the next few years are expected to increase by 58%, indicating a highly optimistic future ahead. This should lead to more robust cash flows, feeding into a higher share value.

What This Means For You

Are you a shareholder? CBRAIN’s optimistic future growth appears to have been factored into the current share price, with shares trading above industry price multiples. However, this brings up another question – is now the right time to sell? If you believe CBRAIN should trade below its current price, selling high and buying it back up again when its price falls towards the industry PE ratio can be profitable. But before you make this decision, take a look at whether its fundamentals have changed.

Are you a potential investor? If you’ve been keeping tabs on CBRAIN for some time, now may not be the best time to enter into the stock. The price has surpassed its industry peers, which means it is likely that there is no more upside from mispricing. However, the positive outlook is encouraging for CBRAIN, which means it’s worth diving deeper into other factors in order to take advantage of the next price drop.

If you'd like to know more about cBrain as a business, it's important to be aware of any risks it's facing. In terms of investment risks, we've identified 1 warning sign with cBrain, and understanding this should be part of your investment process.

If you are no longer interested in cBrain, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

Valuation is complex, but we're here to simplify it.

Discover if cBrain might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About CPSE:CBRAIN

cBrain

A software company, provides software solutions for government, private, education, and non-profit sectors in Denmark, the European Union, and internationally.

High growth potential with excellent balance sheet and pays a dividend.

Advertisement

Weekly Picks

CE
Ceazar
CNXU logo
Ceazar on Conexeu Sciences ·

This small biotech is developing technology that could potentially change how tissue is rebuilt

Fair Value:US$25.3448.6% undervalued
21 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative
HE
HedgeY
PWR logo
HedgeY on Quanta Services ·

The Picks-and-Shovels Leader of the Grid Supercycle

Fair Value:US$7100.7% overvalued
46 users have followed this narrative
0 users have commented on this narrative
4 users have liked this narrative
FU
KRMN logo
FundamentalFlow on Karman Holdings ·

KRMN — Karman Space & Defense: Down 58% from Peak, Is the Market Mispricing a Hypergrowth Defense Compounder?

Fair Value:US$105.650.7% undervalued
25 users have followed this narrative
2 users have commented on this narrative
13 users have liked this narrative
DO
Double_Bubbler
IES logo
Double_Bubbler on Invinity Energy Systems ·

Invinity Energy Systems: All About That BESS

Fair Value:UK£162.0% undervalued
33 users have followed this narrative
0 users have commented on this narrative
5 users have liked this narrative

Updated Narratives

TA
Talos
HYFT logo
Talos on MindWalk Holdings ·

The Asymmetric TechBio Play: MindWalk Holdings and the Valuation Disconnect

Fair Value:US$8.2781.9% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BE
PRCT logo
Betsareoff on PROCEPT BioRobotics ·

PROCEPT BioRobotics sees 17.69% revenue growth and aims for 12.94% profit margin

Fair Value:US$25.2617.2% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
HU
UUE logo
Hunter_Z on UUE Holdings Berhad ·

UUE Holdings Trading at Deep Value Despite Strong Growth Prospects

Fair Value:RM 0.745.7% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

MA
martinarauz
NU logo
martinarauz on Nu Holdings ·

Investment Analysis (May 2026)

Fair Value:US$22.7443.3% undervalued
67 users have followed this narrative
0 users have commented on this narrative
16 users have liked this narrative
HA
HarishPK
ADBE logo
HarishPK on Adobe ·

Adobe: A Probabilistic Case for Undervaluation

Fair Value:US$319.9638.7% undervalued
57 users have followed this narrative
9 users have commented on this narrative
17 users have liked this narrative
NI
niteco
HON logo
niteco on Honeywell International ·

Honeywell - The Demand-Side of the AI Infrastructure

Fair Value:US$320.1928.6% undervalued
52 users have followed this narrative
0 users have commented on this narrative
19 users have liked this narrative